MedPath

Tai Chi Mind-Body Therapy for Chronic Heart Failure

Phase 3
Completed
Conditions
Heart Failure
Interventions
Behavioral: 12-week Tai Chi Program
Behavioral: 12-week Education Program
Registration Number
NCT00110227
Lead Sponsor
Beth Israel Deaconess Medical Center
Brief Summary

The purpose of this study is to determine the effects of a tai chi exercise program on functional capacity and health-related quality of life in patients with chronic heart failure (HF). This study will also examine the way tai chi influences mental, physical, and social functioning.

Detailed Description

HF is a major public health problem in the United States, affecting approximately 5 million adults. Despite recent advances in pharmacologic therapy and technologic devices, HF is the most common reason for hospitalization among Medicare patients and is reaching epidemic proportions as the population ages. New and inexpensive interventions that can improve functional capacity and quality of life and can delay disease progression are needed. Tai chi is a popular mind-body exercise that is a potential treatment for heart disease. This exercise incorporates both gentle physical activity and meditation, and it may be particularly suited to frail patients with HF. This study will examine the effects of a tailored tai chi program on functional capacity and quality of life in patients with HF.

Participants will be randomly assigned to either a tai chi program or heart health education for 12 weeks. Participants in both groups will undergo a bicycle stress test at study entry and will receive weekly training sessions of their assigned intervention. Self-report scales and questionnaires will be used to assess participants at study start and at the end of 12 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Diagnosis of chronic HF
  • Percentage of blood pumped from the left ventricle (ventricular ejection fraction) less than 40% for at least 1 year prior to study entry
  • Stable medical regimen, defined as no major changes in medication, in the 3 months prior to study entry
  • New York Heart Association Classification of Class I (no activity limitations), Class II (slight activity limitations), or Class III (marked activity limitations)
  • English-speaking
Exclusion Criteria
  • Unstable angina, myocardial infarction, cardiac resynchronization, or major cardiac surgery within 3 months prior to study entry
  • History of cardiac arrest or diagnosis of peripartum cardiomyopathy within 6 months prior to study entry
  • Unstable ventricular arrhythmias or structural valvular disease
  • Current participation in a conventional cardiac rehabilitation program
  • Inability to perform a bicycle stress test at study entry
  • Lower extremity amputation or other inability to walk due to conditions other than HF
  • Severe cognitive dysfunction preventing informed consent and understanding of tai chi concept
  • Current regular practice of tai chi
  • Current participation in a tai chi pilot study or other studies

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tai Chi12-week Tai Chi Program12-week tai chi program
Heart Health Education12-week Education Program12-week attention control
Primary Outcome Measures
NameTimeMethod
HF-specific quality of lifebaseline, midpoint, endpoint, 6mo
functional capacitybaseline and endpoint
Walking Testbaseline, midpoint, endpoint
Secondary Outcome Measures
NameTimeMethod
echocardiographybaseline and endpoint
General quality of lifebaseline, midpoint, endpoint, 6mo
mood and emotional statusbaseline, midpoint, endpoint, 6mo
exercise self-efficacybaseline, midpoint, endpoint, 6mo
sense of coherencebaseline, midpoint, endpoint, 6mo
utility assessmentbaseline, midpoint, endpoint, 6mo
beliefs, attitudes, and expectationsbaseline, midpoint, endpoint
physical activity levelbaseline, midpoint, endpoint
perceived social supportbaseline, midpoint, endpoint
neurohormonal statusbaseline, midpoint, endpoint
autonomic tone, heart rate variabilitybaseline and endpoint
costs and use of HF servicesbaseline and endpoint

Trial Locations

Locations (4)

Lown Cardiovascular Center

🇺🇸

Brookline, Massachusetts, United States

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center, Harvard Medical School

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath